6ZRU
Crystal structure of SARS CoV2 main protease in complex with inhibitor Boceprevir
Summary for 6ZRU
Entry DOI | 10.2210/pdb6zru/pdb |
Related | 6ZRT |
Related PRD ID | PRD_002382 |
Descriptor | Main Protease, DIMETHYL SULFOXIDE, boceprevir (bound form), ... (4 entities in total) |
Functional Keywords | protease, boceprevir, inhibitor, viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 |
Total number of polymer chains | 1 |
Total formula weight | 34503.51 |
Authors | Oerlemans, R.,Wang, W.,Lunev, S.,Domling, A.,Groves, M.R. (deposition date: 2020-07-14, release date: 2020-08-12, Last modification date: 2024-01-31) |
Primary citation | Oerlemans, R.,Ruiz-Moreno, A.J.,Cong, Y.,Dinesh Kumar, N.,Velasco-Velazquez, M.A.,Neochoritis, C.G.,Smith, J.,Reggiori, F.,Groves, M.R.,Domling, A. Repurposing the HCV NS3-4A protease drug boceprevir as COVID-19 therapeutics. Rsc Med Chem, 12:370-379, 2020 Cited by PubMed: 34041486DOI: 10.1039/d0md00367k PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report